Multiple sclerosis : clinical and laboratory research
-
Corrigendum to 'Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA' Multiple Sclerosis Journal [Epub ahead of print] [DOI: 10.1177/1352458510394703].
-
Corrigendum to 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis by Trygve Holmøy, Stine Marit Moen, Thomas A Gundersen, Michael F Holick, Enrico Fainardi, Massimiliano Castellazzi and Ilaria Casetta. 15(11) 1280-1285 [DOI: 10.1177/1352458509107008].
-
Corrigendum to Munger, KL and Ascherio A. (2011). Prevention and treatment of MS: studying the effects of vitamin D Multiple Sclerosis Journal 17(12) 1405-1411. [DOI:10.1177/1352458511425366].
-
No large-scale studies have compared the efficacy of intravenous methylprednisolone pulse therapy (IVMP) for multiple sclerosis (MS) and neuromyelitis optica (NMO). ⋯ IVMP is effective in MS from the first to third courses, and in NMO at the first course. Additionally, IVMP is more efficacious in MS than NMO patients, even at the first course.